Moors & Cabot, Inc. Vertex Pharmaceuticals Inc Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Moors & Cabot, Inc. holds 3,578 shares of VRTX stock, worth $1.46 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,578

Previous 3,739 4.31%

Holding current value

$1.46 Million

Previous $1.75 Million 5.02%

% of portfolio

0.08%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$460.0 - $505.78 $74,060 - $81,430	-161 Reduced 4.31%	3,578 $1.66 Million
Q2 2024 Aug 09, 2024	SELL	$392.81 - $485.53 $78,954 - $97,591	-201 Reduced 5.1%	3,739 $1.75 Million
Q1 2024 May 08, 2024	BUY	$407.69 - $446.08 $19,161 - $20,965	47 Added 1.21%	3,940 $1.65 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $144,746 - $173,306	-422 Reduced 9.78%	3,893 $1.58 Million
Q3 2023 Nov 07, 2023	SELL	$338.18 - $362.46 $63,916 - $68,504	-189 Reduced 4.2%	4,315 $1.5 Million
Q2 2023 Aug 09, 2023	BUY	$314.42 - $351.91 $129,541 - $144,986	412 Added 10.07%	4,504 $1.59 Million
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $54,946 - $62,681	-194 Reduced 4.53%	4,092 $1.29 Million
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $324,051 - $364,558	1,134 Added 35.98%	4,286 $1.24 Million
Q4 2022 Feb 06, 2023	SELL	$285.76 - $321.48 $267,471 - $300,905	-936 Reduced 22.9%	3,152 $910,000
Q3 2022 Nov 07, 2022	BUY	$273.83 - $305.53 $6,298 - $7,027	23 Added 0.57%	4,088 $1.18 Million
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $42,762 - $53,244	182 Added 4.69%	4,065 $1.15 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $155,215 - $182,939	701 Added 22.03%	3,883 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $4.75 Million - $5.99 Million	-26,818 Reduced 89.39%	3,182 $699,000
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $5.44 Million - $6.09 Million	30,000 New	30,000 $29,000
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $339,926 - $396,231	-1,642 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $33,949 - $45,278	-164 Reduced 9.08%	1,642 $387,000
Q3 2020 Nov 09, 2020	SELL	$255.65 - $303.1 $55,987 - $66,378	-219 Reduced 10.81%	1,806 $491,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $10,597 - $13,902	47 Added 2.38%	2,025 $591,000
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $57,134 - $70,873	-286 Reduced 12.63%	1,978 $474,000
Q4 2019 Jan 28, 2020	BUY	$166.71 - $223.91 $377,431 - $506,932	2,264 New	2,264 $496,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account